智通财经APP获悉，心脏植入物开发商Encore Medical周二公布了其首次公开募股(IPO)条款。该公司计 划以每股5美元的价格发行300万股股票，筹资1500万美元。该公司计划在纽交所上市，股票代码 为"EMI"。 据悉，Encore Medical总部位于美国明尼苏达州伊根。该公司开发和生产室间隔闭塞装置，这是一种通 过导管输送的植入式产品，用于修复某些心脏缺陷，如卵圆孔未闭(PFO)。该公司的设备已被批准在欧 盟销售，虽然它还没有获得在美国销售其设备的监管批准，但该公司已获得美国食品药品管理局(FDA) 的批准，可以进行试验以获得市场许可。数据显示，该公司在截至2025年9月30日的12个月营收为200万 美元。 ...

TABLE OF CONTENTS REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON DECEMBER 30, 2025 Registration No. 333-290244 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENCORE MEDICAL, INC. (Exact name of registrant as specified in its charter) 3841 (Primary Standard Industrial Classification Code Number) Minnesota (State or other jurisdiction of inc ...

Group 1 - The article discusses the services provided by IPO Edge, which includes actionable information on growth stocks, first-look IPO filings, previews of upcoming IPOs, an IPO calendar, a database of U.S. IPOs, and a comprehensive guide to IPO investing [1]

TABLE OF CONTENTS REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 12, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENCORE MEDICAL, INC. (Exact name of registrant as specified in its charter) 3841 Minnesota (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Numb ...